FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2558534037> ?p ?o ?g. }

• W2558534037 endingPage "1667" @default.
• W2558534037 startingPage "1655" @default.
• W2558534037 abstract "// Li Peng 1, 2 , Xiao-Qing Yuan 3, 4, * , Zhao-Yang Liu 1, 2 , Wen-Ling Li 1, 2 , Chao-Yang Zhang 1, 2 , Ya-Qin Zhang 1, 2 , Xi Pan 5 , Jun Chen 1, 2 , Yue-Hui Li 1, 2 , Guan-Cheng Li 1, 2, * 1 Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha 410078, P.R. China 2 Cancer Research Institute, Central South University, Changsha 410078, P.R. China 3 Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, P.R. China 4 Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, P.R. China 5 Department of Oncology, The third Xiangya Hospital, Central South University, Changsha 410013, P.R. China * These authors have contributed equally to this work Correspondence to: Guan-Cheng Li, email: ligc61@csu.edu.cn or libsun@163.com Keywords: H19, prognosis, female cancers, TCGA, meta-analysis Received: June 30, 2016     Accepted: November 14, 2016     Published: December 01, 2016 ABSTRACT Upregulation of lncRNA H19 expression is associated with an unfavorable prognosis in some cancers. However, the prognostic value of H19 in female-specific cancers has remained uncharacterized. In this study, the prognostic power of high H19 expression in female cancer patients from the TCGA datasets was analyzed using Kaplan-Meier survival curves and Cox’s proportional hazard modeling. In addition, in a meta-analysis of non-female cancer patients from TCGA datasets and 12 independent studies, hazard ratios (HRs) with 95% confidence interval (CI) for overall survival (OS) and disease-free survival (DFS)/relapse-free survival (RFS)/metastasis-free survival (MFS)/progression-free survival (PFS) were pooled to assess the prognostic value of high H19 expression. Kaplan-Meier analysis revealed that patients with uterine corpus cancer and higher H19 expression had a shorter OS (HR=2.710, p <0.05), while females with cervical cancer and increased H19 expression had a shorter RFS (HR=2.261, p <0.05). Multivariate Cox regression analysis showed that high H19 expression could independently predict a poorer prognosis in cervical cancer patients (HR=4.099, p <0.05). In the meta-analysis, patients with high H19 expression showed a poorer outcome in non-female cancer ( p <0.05). These results suggest that high lncRNA H19 expression is predictive of an unfavorable prognosis in two female cancers (uterine corpus endometrioid cancer and cervical cancer) as well as in non-female cancer patients." @default.
• W2558534037 created "2016-12-08" @default.
• W2558534037 creator A5001989498 @default.
• W2558534037 creator A5002028745 @default.
• W2558534037 creator A5031438011 @default.
• W2558534037 creator A5039967620 @default.
• W2558534037 creator A5055108690 @default.
• W2558534037 creator A5073580810 @default.
• W2558534037 creator A5082857859 @default.
• W2558534037 creator A5083065267 @default.
• W2558534037 creator A5084555036 @default.
• W2558534037 creator A5091040124 @default.
• W2558534037 date "2016-12-01" @default.
• W2558534037 modified "2023-10-06" @default.
• W2558534037 title "High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers" @default.
• W2558534037 cites W1497817735 @default.
• W2558534037 cites W1757407923 @default.
• W2558534037 cites W1778682794 @default.
• W2558534037 cites W1791218006 @default.
• W2558534037 cites W1814564269 @default.
• W2558534037 cites W1976988381 @default.
• W2558534037 cites W2075642745 @default.
• W2558534037 cites W2079565353 @default.
• W2558534037 cites W2087377443 @default.
• W2558534037 cites W2088095316 @default.
• W2558534037 cites W2105347414 @default.
• W2558534037 cites W2111479290 @default.
• W2558534037 cites W2112657305 @default.
• W2558534037 cites W2130543801 @default.
• W2558534037 cites W2136120736 @default.
• W2558534037 cites W2147689539 @default.
• W2558534037 cites W2148968940 @default.
• W2558534037 cites W2150356383 @default.
• W2558534037 cites W2150936111 @default.
• W2558534037 cites W2160911489 @default.
• W2558534037 cites W217432650 @default.
• W2558534037 cites W2201374517 @default.
• W2558534037 cites W2212574056 @default.
• W2558534037 cites W2259986057 @default.
• W2558534037 cites W2268810348 @default.
• W2558534037 cites W2269231667 @default.
• W2558534037 cites W2276137469 @default.
• W2558534037 cites W2300010382 @default.
• W2558534037 cites W2320476296 @default.
• W2558534037 cites W2331909717 @default.
• W2558534037 cites W2335954491 @default.
• W2558534037 cites W2342151954 @default.
• W2558534037 cites W2346560849 @default.
• W2558534037 cites W2396888315 @default.
• W2558534037 cites W2412926120 @default.
• W2558534037 cites W2511206720 @default.
• W2558534037 cites W2517114205 @default.
• W2558534037 doi "https://doi.org/10.18632/oncotarget.13768" @default.
• W2558534037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5352086" @default.
• W2558534037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27926484" @default.
• W2558534037 hasPublicationYear "2016" @default.
• W2558534037 type Work @default.
• W2558534037 sameAs 2558534037 @default.
• W2558534037 citedByCount "22" @default.
• W2558534037 countsByYear W25585340372017 @default.
• W2558534037 countsByYear W25585340372018 @default.
• W2558534037 countsByYear W25585340372019 @default.
• W2558534037 countsByYear W25585340372020 @default.
• W2558534037 countsByYear W25585340372021 @default.
• W2558534037 countsByYear W25585340372022 @default.
• W2558534037 countsByYear W25585340372023 @default.
• W2558534037 crossrefType "journal-article" @default.
• W2558534037 hasAuthorship W2558534037A5001989498 @default.
• W2558534037 hasAuthorship W2558534037A5002028745 @default.
• W2558534037 hasAuthorship W2558534037A5031438011 @default.
• W2558534037 hasAuthorship W2558534037A5039967620 @default.
• W2558534037 hasAuthorship W2558534037A5055108690 @default.
• W2558534037 hasAuthorship W2558534037A5073580810 @default.
• W2558534037 hasAuthorship W2558534037A5082857859 @default.
• W2558534037 hasAuthorship W2558534037A5083065267 @default.
• W2558534037 hasAuthorship W2558534037A5084555036 @default.
• W2558534037 hasAuthorship W2558534037A5091040124 @default.
• W2558534037 hasBestOaLocation W25585340371 @default.
• W2558534037 hasConcept C121608353 @default.
• W2558534037 hasConcept C126322002 @default.
• W2558534037 hasConcept C138885662 @default.
• W2558534037 hasConcept C143998085 @default.
• W2558534037 hasConcept C17744445 @default.
• W2558534037 hasConcept C191935318 @default.
• W2558534037 hasConcept C199539241 @default.
• W2558534037 hasConcept C207103383 @default.
• W2558534037 hasConcept C27206212 @default.
• W2558534037 hasConcept C2781354324 @default.
• W2558534037 hasConcept C29456083 @default.
• W2558534037 hasConcept C44249647 @default.
• W2558534037 hasConcept C50382708 @default.
• W2558534037 hasConcept C521751864 @default.
• W2558534037 hasConcept C54355233 @default.
• W2558534037 hasConcept C555283112 @default.
• W2558534037 hasConcept C556039675 @default.
• W2558534037 hasConcept C71924100 @default.
• W2558534037 hasConcept C86803240 @default.
• W2558534037 hasConceptScore W2558534037C121608353 @default.

• next